Mpox Job Aids

CAPTC is pleased to announce two job aids, focused on mpox recognition, diagnosis, testing, treatment, and vaccination.

The shorter job aid is called “Mpox Clinical Recognition and Testing Quicksheet: Mpox Presentations vs. Common Exanthems.” It is intended as a print resource, to help facilitate clinical recognition of mpox in health care settings. The longer job aid, “Mpox Clinical Recognition and Testing Overview,” is intended as an electronic resource. It has links to a number of helpful mpox-related resources.

Mpox Clinical Recognition and Testing Quicksheet

Mpox Clinical Recognition and Testing Overview

You can find the sources of images used in the quicksheet here:

Image Sources

Mpox Disease Intervention Series

The goal of this training is to prepare staff of local health departments to perform effective disease intervention (DI) interviews for mpox. This training aims to build on disease intervention skills by applying knowledge of the complexities and nuances specifically related to mpox DI interviews.

Go To Trainings

Learning Objectives
By the end of these trainings, you should be able to:

Communicate accurate information about mpox symptoms, transmission, prevention, treatment, and services.
Gain awareness of the lived experiences of gay, bi, other men who have sex with men (MSM), including transgender men, and other trans people as it relates to mpox.
Understand a sex-positive, person-centered approach to taking a sexual history for mpox.
Use motivational interviewing and health coaching tools to support clients in seeking vaccination, screening, or treatment for mpox.
Examine personal and structural biases to reduce stigma during mpox interviews.

STI Clinical Update Webinar: California Mpox Update for Healthcare Providers – October 2023

Thursday, October 26, 2023
12:00 PM – 1:30 PM (PDT)

The California Department of Public Health (CDPH) continues to see statewide Mpox activity, including a large cluster in Los Angeles County. This webinar, presented by the California Prevention Training Center (CAPTC), features CDPH’s Mpox Clinical and Epidemiology teams, who will provide a clinical update and epidemiological overview of Mpox, and discuss new research findings relevant to primary care and other healthcare providers, including data on transmission, vaccine equity, and vaccine effectiveness. A question-and-answer session will follow.

Presented by:

Kayla Saadeh, MPH
Mpox Epidemiology Unit Lead
California Department of Public Health

Jessica Watson, MD, MPH
Mpox Public Health Medical Officer and Acting Clinical Lead
California Department of Public Health

Learning Objectives

Identify the clinical and epidemiological factors leading to Mpox infection, transmission, and severity as well as treatment options.
Apply the latest information and research on Mpox, including transmission characteristics, vaccine equity, and vaccine effectiveness, to your clinical practice to ensure patients are appropriately vaccinated, diagnosed, tested, and treated for Mpox.

Please note: CME not available for viewing the webinar recording.

STI Clinical Program Update: Mpox letter and Bicillin shortage

STI Clinical Program Updates: Mpox letter and Bicillin shortage

The California Department of Public Health (CDPH) STD Control Branch has released two new important communications on: (1) Preventing a Resurgence of Mpox Cases in California and (2) Addressing an ongoing Bicillin® L-A shortage.

(1) Dear Colleague Letter: Preventing a Resurgence of Mpox Cases in California

CDPH is aware that – while the rate of California (CA) mpox cases has declined precipitously since its peak in August 2022 – mpox transmission has continued in CA, and other states have recently reported a resurgence of mpox cases. Accordingly, CDPH has released a new Dear Colleague Letter intended as a call to action to Californian health care providers to remain vigilant in mpox prevention, recognition, and testing. This is especially important during the upcoming 2023 spring and summer season as people gather for festivals and events, including LGBTQ Pride Month in June. Information on how to diagnose, test for, and vaccinate against mpox is included.

(2) Health Advisory: Bicillin® L-A (Benzathine Penicillin G) Shortage

The Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) have announced a shortage of long-acting penicillin G benzathine injectable suspension products (Bicillin® L-A), with an estimated recovery timeframe not until Q4 of 2023. This is of considerable concern in CA, as the state continues to see significant increases in syphilis — including syphilis in pregnant persons and congenital syphilis in infants. CDPH has thus issued a Health Advisory addressing the Bicillin® L-A shortage, providing a framework for prioritization of limited Bicillin® L-A supplies when necessary, and recommending doxycycline as an alternative to Bicillin® L-A in appropriate clinical scenarios.

Sincerely,

California Prevention Training Center

Preventing Occupational Mpox Transmission in Outpatient Clinics

This resource includes practical tips for preventing mpox transmission in an outpatient setting, as implemented by many sexual health clinics during the current mpox outbreak. When space and resources are scarce or limited, implementing these real-world strategies allows clinics to care for patients with mpox as safely and effectively as possible.

View digital version (Includes hyperlinks)

View print version

STI Clinical Update Webinar-Back to Basics: Fundamentals of STI/HIV Prevention

Tuesday, March 28, 2023 from 12:00-1:15PM (PDT)
A review of screening, treatment, and vaccination tools to prevent STIs and HIV.
Presented by Drs. Caterina Liu and Kurtis Mohr

Learning Objectives:

Review screening and treatment guidance for STIs and HIV.
Integrate biochemical prevention tools for STIs and HIV into clinical practice.
Summarize recommendations for Hepatitis A, Hepatitis B, HPV, meningitis, and mpox vaccination.

STI Clinical Update Webinar: Syndromic Management of STIs – Part 2

Tuesday, December 6, 2022 from 12:00PM-1:15PM (PST)

Presented by Drs. Kathleen Jacobson and Kelly Johnson

A case-based approach to recognizing sexually transmitted infections, with a focus on those that disseminate outside the genital tract.

Learning Objectives

Identify various presentations of STI ulcerative disease
Understand that certain sexually transmitted infections (STIs) can disseminate outside the genital tract, sometimes causing severe disease
Recognize the varied clinical manifestations of disseminated STIs (including disseminated gonococcal infections, secondary syphilis, and mpox)
Understand how to diagnose and manage disseminated STIs

Mpox Frequently Asked Questions

Excellent FAQs and resources from Building Healthy Online Communities on the latest in mpox (formerly known as monkeypox) prevention, transmission, symptoms, and treatment. Updated regularly.

View Site

Mpox: Monitoring and Risk Assessment for Persons Exposed in the Community

CDC guidance intended for people who have had mpox exposures in the community. Includes who should be monitored, what to monitor, and how to monitor.

Visit site

S3 E14: Monkeypox: Where are We Now? with Dr. Peter Chin-Hong

Listen now

Host Tammy Kremer chats with UCSF Infectious Disease Specialist Dr. Peter Chin-Hong about the current state of the Mpox outbreak: how it reflects contemporary health inequities, how stigma can be a barrier to people accessing treatment, and how lessons learned from past public health crises shaped the clinical and community response. Dr. Chin-Hong speaks about his experience caring for Mpox patients over the course of the outbreak, and how the stigma surrounding the virus has discouraged individuals from seeking out the necessary care, creating invisible populations of patients who are disconnected from diagnosis and treatment. Finally, he breaks down the social and behavioral interventions that have been effective in slowing the spread of the virus over the past months. They explore the role of public health education and messaging in the Mpox outbreak and how Dr. Chin-Hong anticipates the outbreak may proceed.

Read the transcript of the episode here.

CAPTC-Related Training and Resources:

S3 E8: Monkeypox in California: A Personal Story and Public Health Perspective

S3 E3: Monkeypox, What’s the Hype?

CAPTC Monkeypox FAQ’s

CDC Monkeypox Resource Center

Turn on notifications to never miss an episode of Coming Together for Sexual Health.

Follow Coming Together for Sexual Health on Instagram and Twitter.

Peter Chin-Hong, MD, is a professor of medicine and associate dean at UCSF. He specializes in treating infectious diseases, especially in immunosuppressed patients such as recipients of organ and stem cell transplants and HIV-positive recipients of organ transplants. He is regularly featured in the media discussing COVID-19 and Mpox.